774 Amorphous Solid Dispersions for Drug Product

Friday, November 18, 2016: 12:30 PM - 3:00 PM
Continental 4 (Hilton San Francisco Union Square)
Description:
Amorphous Solid Dispersions for Drug Product

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Particle Production and Characterization (03A), Pharmaceuticals (15B)

Chair:
Trey Porter
Email: wporterIII@dow.com

Co-Chair:
Christopher L. Burcham
Email: cburcham@lilly.com


12:30 PM
(774a) Understanding the Role of Hpmcas in Phenytoin Solid Dispersion Formulation Using Coarse Grained Molecular Dynamics Simulations
Wenjun Huang and Ronald G. Larson

12:50 PM
(774b) Assessing the Efficacy of Thermo-Responsive Poly(N-isopropylacrylamide) in Phenytoin Solid Dispersion Formulation Using Atomistic Molecular Dynamics Simulations
Soroush Moghadam and Ronald G. Larson

1:10 PM
(774c) Solid State Form Understanding Applied to the Design of a Spray Dried Dispersion Process: A Quality By Design Approach to Optimization of Feed Solution Loading
Kyle Blakely and Christopher L. Burcham

1:30 PM
(774d) Ternary Dispersions of Itraconazole: A Comparison of Hot Melt Extrusion and Spray Drying
Mark Davis, Catherine Kelly and Gavin Walker

1:50 PM
Break

2:10 PM
(774f) Tunable Drug Loaded Stable and Fast Release Amorphous Composites Production Using Mesoporous Neusilin®UFL2
Mohammad Azad, Jacqueline Moreno, Meng Li and Rajesh Dave

2:30 PM
(774g) Hot Melt Extrusion of Ternary Solid Dispersions of Itraconazole: Amorphous Vs Liquid Crystal Intermediate
Ahmad B. Albadarin, Catherine Kelly, Mark Davis, Maryam Mohammadpour, Sachin Korde, Sudhir Pagire, Anant Paradkar and Gavin Walker
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>